Antisoma Research: Clinical Trials

11 trials sponsored by Antisoma Research, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 unknown, 2 terminated. 7 Phase 2, 4 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 27Completed 3, Terminated 2, Unknown 2
Phase 14Completed 4
Phase 31Unknown 1

Follow Antisoma Research: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients With Acute Myeloid Leukemia (AML)
Amonafide + cytarabine - Acute Myeloid Leukemia
Phase 2UnknownAntisoma Research202010-01-012011-01-17
A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia
AS1411, Cytarabine - Acute Myeloid Leukemia
Phase 2TerminatedAntisoma Research902010-01-012011-02-02
Phase II Study of AS1402 Combined With Letrozole to Treat Breast Cancer
AS1402, Letrozole - Breast Carcinoma
Phase 2TerminatedAntisoma Research1102008-09-012009-08-10
A Phase II Study of AS1411 in Renal Cell Carcinoma
AS1411 - Metastatic Renal Cell Carcinoma
Phase 2UnknownAntisoma Research302008-08-012009-09-25
Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma
AS1409 - Metastatic Renal Cell Carcinoma, Metastatic Malignant Melanoma
Phase 1CompletedAntisoma Research132008-01-012009-08-25
Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia
AS1411 - Leukemia, Myeloid
Phase 2CompletedAntisoma Research702007-07-012009-09-25
Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study
Daunorubicin and Cytarabine, Amonafide and Cytarabine - Secondary Acute Myeloid Leukemia (Secondary AML, sAML)
Phase 3UnknownAntisoma Research4202007-06-012010-10-13
Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer
AS1404 (DMXAA) - Prostate Cancer
Phase 2CompletedAntisoma Research702005-05-012009-01-30
Phase II Study of DMXAA (ASA404) in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer
DMXAA in combination with carboplatin and paclitaxel - Non-Small Cell Lung Cancer
Phase 1 / Phase 2CompletedAntisoma Research1052004-09-012009-01-30
Study of AS1411 in Advanced Solid Tumours
AS1411 - Advanced Solid Tumors
Phase 1CompletedAntisoma Research302003-09-012009-04-15
Phase I Safety Study of DMXAA in Refractory Tumors
DMXAA - Refractory Tumors
Phase 1CompletedAntisoma Research152003-05-012009-03-05

Conditions studied

Carcinoma, Renal Cell (2)  ·  Leukemia (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Acute Disease (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Kidney Neoplasms (1)  ·  Leukemia, Myeloid (1)  ·  Lymphatic Diseases (1)  ·  Melanoma (1)  ·  Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Recurrence (1)

Interventions

AGRO 100 (4)  ·  Cytarabine (3)  ·  vadimezan (3)  ·  amonafide (2)  ·  AS1409 protein (1)  ·  Carboplatin (1)  ·  Daunorubicin (1)  ·  Letrozole (1)  ·  Paclitaxel (1)  ·  epitumomab (1)

Countries

United States (6)  ·  New Zealand (3)  ·  Australia (2)  ·  Russia (2)  ·  Taiwan (2)  ·  Ukraine (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Austria (1)  ·  Belgium (1)  ·  Canada (1)  ·  Chile (1)  ·  Czechia (1)  ·  Ecuador (1)  ·  Estonia (1)

Top investigators

Mark McKeage (2)  ·  Gary Acton, MA MBBS MRCP (1)  ·  Greg Smith, MD (1)  ·  Harry Drabkin, MD (1)  ·  James Spicer, MD (1)  ·  Mark Jeffery (1)  ·  Michael Jameson (1)  ·  Nuhad K Ibrahim, MD FACP (1)  ·  Rob Stuart, MD (1)  ·  Roberto Pili, MD (1)

Results publications

PMID 16551862, PMID 17356709, PMID 19387077, PMID 21447719, PMID 21878535, PMID 22263047, PMID 24242861, PMID 25550361, PMID 25732165, PMID 40443562